SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001842952-23-000070
Filing Date
2023-06-20
Accepted
2023-06-20 08:35:52
Documents
12
Period of Report
2023-06-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K cntx-20230615.htm   iXBRL 8-K 32885
  Complete submission text file 0001842952-23-000070.txt   180982

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20230615.xsd EX-101.SCH 1937
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20230615_lab.xml EX-101.LAB 26871
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20230615_pre.xml EX-101.PRE 14143
6 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20230615_htm.xml XML 11842
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40654 | Film No.: 231023500
SIC: 2834 Pharmaceutical Preparations